Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001130319-06-000214
Filing Date
2006-03-23
Accepted
2006-03-23 16:28:09
Documents
6
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K o30708e10vk.htm 10-K 834607
2 CONSENT OF DELOITTE & TOUCHE LLP o30708exv23w1.htm EX-23.1 2005
3 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 o30708exv31w1.htm EX-31.1 8501
4 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 o30708exv31w2.htm EX-31.2 8504
5 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION o30708exv32w1.htm EX-32.1 3355
6 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION o30708exv32w2.htm EX-32.2 3364
  Complete submission text file 0001130319-06-000214.txt   861762
Mailing Address 50 AUDUBON ROAD SUITE B WAKEFIELD MA 01880
Business Address 50 AUDUBON ROAD SUITE B WAKEFIELD MA 01880 781-224-1444
NUCRYST Pharmaceuticals Corp. (Filer) CIK: 0001344674 (see all company filings)

EIN.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51686 | Film No.: 06706405
SIC: 2834 Pharmaceutical Preparations